当前位置:首页 - 行情中心 - 圣湘生物(688289) - 财务分析

圣湘生物

(688289)

  

流通市值:127.29亿  总市值:127.29亿
流通股本:5.79亿   总股本:5.79亿

圣湘生物(688289)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.62亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益722008.98万元,未分配利润478312.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产946418.67万元,负债224409.69万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,244,138,989.62868,620,485.26475,488,325.651,458,061,552.96
营业总成本1,066,909,188.78702,919,097.81360,282,099.931,278,340,817.64
其他经营收益
营业利润197,307,297.13191,549,753.11101,093,316.29277,776,647.72
利润总额179,774,191.79170,608,533.6799,147,525.58260,611,038.68
净利润161,975,915.54142,740,148.1580,633,918.47226,272,700.73
每股收益
其他综合收益-1,751,561.64607,182.97161,778.27-4,533,779.91
综合收益总额160,224,353.9143,347,331.1280,795,696.74221,738,920.82
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,304,688,974.995,382,425,770.875,776,190,273.855,789,559,824.3
非流动资产:
非流动资产合计4,159,497,737.014,137,507,471.863,908,114,618.512,814,236,319.4
资产总计9,464,186,7129,519,933,242.739,684,304,892.368,603,796,143.7
流动负债:
流动负债合计1,087,825,915.221,155,569,953.811,301,244,161.97754,803,131.59
非流动负债:
非流动负债合计1,156,270,967.521,010,715,687.89950,177,283.84503,207,461.38
负债合计2,244,096,882.742,166,285,641.72,251,421,445.811,258,010,592.97
所有者权益(或股东权益):
归属于母公司股东权益合计7,130,763,929.237,254,955,843.647,341,425,327.37,243,225,866.27
股东权益合计7,220,089,829.267,353,647,601.037,432,883,446.557,345,785,550.73
负债和股东权益合计9,464,186,7129,519,933,242.739,684,304,892.368,603,796,143.7
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,276,260,976.7785,729,209.73384,527,693.051,883,267,047.23
经营活动现金流出小计1,360,741,028.37928,576,050.75418,344,339.521,608,819,191.12
经营活动产生的现金流量净额-84,480,051.67-142,846,841.02-33,816,646.47274,447,856.11
投资活动产生的现金流量:
投资活动现金流入小计996,450,999.11715,866,825.58255,981,677.461,545,655,255.36
投资活动现金流出小计1,992,442,263.211,615,358,695.17843,481,221.181,647,576,859.67
投资活动产生的现金流量净额-995,991,264.1-899,491,869.59-587,499,543.72-101,921,604.31
筹资活动产生的现金流量:
筹资活动现金流入小计1,109,084,474.13949,084,474.13823,302,199.13432,176,986.68
筹资活动现金流出小计759,047,028.32580,155,764.45415,160,798.54299,686,336.98
筹资活动产生的现金流量净额350,037,445.81368,928,709.68408,141,400.59132,490,649.7
汇率变动对现金及现金等价物的影响-389,317.971,279,806.12185,714.52-3,296.46
现金及现金等价物净增加额-730,823,187.93-672,130,194.81-212,989,075.08305,013,605.04
期末现金及现金等价物余额3,745,804,828.993,804,497,822.114,263,638,941.844,476,628,016.92
补充资料:
现金及现金等价物的净增加额--672,130,194.81-305,013,605.04
最新报告期:2025-10-31
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
湘财证券蒋栋0.530.630.702025-10-31
中信建投王在存,贺菊颖0.540.650.802025-10-10
华安证券李婵,谭国超0.620.781.022025-09-05
信达证券唐爱金,曹佳琳0.540.700.862025-09-02
华源证券刘闯,林海霖0.520.700.942025-09-01
TOP↑